3
Announcements
Trials
Browse
Landscape
Status
Completed
40
Recruiting
17
Unknown
11
Active not recruiting
10
Terminated
7
Withdrawn
5
Not yet recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other solid neoplasm
1
Other hematologic neoplasm
1
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Interventions
Fluorodeoxyglucose F18
3
pembrolizumab
2
sacituzumab govitecan
1
ibrutinib
1
erdafitinib
1
enzalutamide
1
enfortumab vedotin
1
dynorphin-converting endopeptidase
1
avelumab
1
apixaban
1
Vinblastine
1
Surveys and Questionnaires
1
Specimen Handling
1
Radiosurgery
1
Pancreatectomy
1
Paclitaxel
1
Nivolumab
1
Methotrexate
1
Magnetic Resonance Imaging
1
JNJ-64619178
1
JNJ-64264681
1
Inosine Monophosphate
1
Health Information Exchange
1
Genetic Testing
1
Genetic Counseling
1
Gemcitabine
1
Focus Groups
1
Enoxaparin
1
Docetaxel
1
Cystoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Surveys and Questionnaires
×
Genitourinary
×
Clear all
NCT04254133
2026-01-30
GIFTS
Fred Hutchinson Cancer Center
Enrolling by invitation
1,360 enrolled